Browse All

Current Filters

CLEAR FILTER x

TITLE

Optimizing a Patient’s Oral CD-LD Dosing Regimen Is Critical for Improving Efficacy in Parkinson’s Disease

Author:Hauser, Robert   Moore, Henry   Banisadr, Ghazal   D'Souza, Richard   

Session Name:P4: Movement Disorders: Parkinson's Disease Clinical Aspects 1  

Topic:Movement Disorders  

Program Number:P4.019  

Author Institution:Movement Disorders Center, Tampa, FL  University of Miami - Miller School of Medicine, Miami, FL  Amneal Pharmaceuticals, Evanston, IL  Amneal Pharmaceuticals, Morristown, NJ  

Safety Profile of IPX203 in Patients Exposed for 12 Months in a Phase 3 Study in PD by Modal Dose Distribution

Author:Ondo, William   Fisher, Stanley   Banisadr, Ghazal   D'Souza, Richard   Hauser, Robert   

Session Name:P9: Movement Disorders: Parkinson's Disease Clinical Trials  

Topic:Movement Disorders  

Program Number:P9.004  

Author Institution:Methodist Neurological Institute, Houston, TX  Amneal Pharmaceuticals, Warren, NJ  Amneal Pharmaceuticals, Evanston, IL  Amneal Pharmaceuticals, Morristown, NJ  Movement Disorders Center, Tampa, FL